{"id":20216,"date":"2014-04-24T10:10:14","date_gmt":"2014-04-24T14:10:14","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=20216"},"modified":"2014-04-24T10:10:14","modified_gmt":"2014-04-24T14:10:14","slug":"valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216","title":{"rendered":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Is A Place Hedge Funds Love To Play"},"content":{"rendered":"<p style=\"text-align: justify;\"><em>Boston, MA 04\/24\/2014 (wallstreetpr) \u00a0&#8211; \u00a0<\/em><b>Valeant Pharmaceuticals Intl Inc (NYSE:VRX)<\/b> is a $44 billion company with corporate headquarters in Quebec, Canada. The company manufactures and markets various pharmaceutical products.<\/p>\n<p style=\"text-align: justify;\">It recently placed a bid to acquire <b>Allergan, Inc. (NYSE:AGN)<\/b>. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) teamed with investor Bill Ackman , who runs a hedge fund called Pershing Square Capital Management, to place a bid for Allergan.<\/p>\n<p style=\"text-align: justify;\">But Pershing Square Capital Management is not the only prominent hedge fund that highly rates Valeant in terms of big investment. The company is teaming with many prominent hedge funds that have not only been increasing their stake, but also have long positions.<\/p>\n<p style=\"text-align: justify;\">Several hedge funds rank Valeant among their top 10 stock investments, according to <b>Goldman Sachs Group Inc (NYSE:GS)<\/b>.<\/p>\n<p style=\"text-align: justify;\"><b>Prominent hedge funds in Valeant<\/b><\/p>\n<p style=\"text-align: justify;\">ValueAct Capital Management LP is one big hedge fund that has held stake in Valeant for years. The firm entered an activist stake in Valeant about eight years ago. ValueAct held about 18.9 million shares of Valeant as of the end of 2013, according to regulatory documents. The firm\u2019s entry into Valeant helped it to support the hiring of a new CEO and structuring the CEO\u2019s compensation plan.<\/p>\n<p style=\"text-align: justify;\">Another prominent hedge fund that has long been bullish on Valeant is Viking Global Investment LP. According to regulatory filing, Viking, a fund managed by Andreas Halvorsen, held 8.3 million shares in Valeant and about 1.4 million shares in Allergan as of the end of 2013.<\/p>\n<p style=\"text-align: justify;\">Several other prominent funds including Maverick Capital Ltd., Lone Pine Capital LLC, Ratan Capital Management LP and Hound Partners LLC hold shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX).<\/p>\n<p style=\"text-align: justify;\"><b>Bid for Allergan<\/b><\/p>\n<p style=\"text-align: justify;\">Valeant Pharmaceuticals Intl Inc (NYSE:VRX) offered to pay $48.30 in cash for each share of Allergan and offer 0.83 of its own shares to take over the company. The deal values Allergan at $46 billion or $152.89 per share. Pershing Square Capital Management, the hedge fund run by Mr. Ackman that has teamed up with Valeant to acquired Allergan, recently invested $4 billion in Allergan to acquire 9.7 percent stake.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 04\/24\/2014 (wallstreetpr) \u00a0&#8211; \u00a0Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a $44 billion company with corporate headquarters in Quebec, Canada. The company manufactures and [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":20218,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[6035,1865,6036,734,2046,2045],"stock_ticker":[],"class_list":["post-20216","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-allergan-inc-nyseagn","tag-goldman-sachs-group-inc-nysegs","tag-nyseagn","tag-nysegs","tag-nysevrx","tag-valeant-pharmaceuticals-intl-inc-nysevrx","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Is A Place Hedge Funds Love To Play - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Is A Place Hedge Funds Love To Play - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 04\/24\/2014 (wallstreetpr) \u00a0&#8211; \u00a0Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a $44 billion company with corporate headquarters in Quebec, Canada. The company manufactures and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-04-24T14:10:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"168\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Is A Place Hedge Funds Love To Play\",\"datePublished\":\"2014-04-24T14:10:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216\"},\"wordCount\":354,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download3.jpg\",\"keywords\":[\"Allergan Inc. (NYSE:AGN)\",\"Goldman Sachs Group Inc (NYSE:GS)\",\"NYSE:AGN\",\"NYSE:GS\",\"NYSE:VRX\",\"Valeant Pharmaceuticals Intl Inc (NYSE:VRX)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216\",\"name\":\"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Is A Place Hedge Funds Love To Play - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download3.jpg\",\"datePublished\":\"2014-04-24T14:10:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download3.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download3.jpg\",\"width\":300,\"height\":168},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Is A Place Hedge Funds Love To Play\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Is A Place Hedge Funds Love To Play - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216","og_locale":"en_US","og_type":"article","og_title":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Is A Place Hedge Funds Love To Play - Wall Street PR","og_description":"Boston, MA 04\/24\/2014 (wallstreetpr) \u00a0&#8211; \u00a0Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a $44 billion company with corporate headquarters in Quebec, Canada. The company manufactures and [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-04-24T14:10:14+00:00","og_image":[{"width":300,"height":168,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download3.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Is A Place Hedge Funds Love To Play","datePublished":"2014-04-24T14:10:14+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216"},"wordCount":354,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download3.jpg","keywords":["Allergan Inc. (NYSE:AGN)","Goldman Sachs Group Inc (NYSE:GS)","NYSE:AGN","NYSE:GS","NYSE:VRX","Valeant Pharmaceuticals Intl Inc (NYSE:VRX)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216","url":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216","name":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Is A Place Hedge Funds Love To Play - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download3.jpg","datePublished":"2014-04-24T14:10:14+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download3.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download3.jpg","width":300,"height":168},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-is-a-place-hedge-funds-love-to-play-20216#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Is A Place Hedge Funds Love To Play"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/20216","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=20216"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/20216\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/20218"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=20216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=20216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=20216"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=20216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}